Log in to save to my catalogue

α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human...

α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_26467761

α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models

About this item

Full title

α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2016-02, Vol.113 (7), p.1931-1936

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Parkinson’s disease (PD) is an age-related neurodegenerative disorder characterized by the accumulation of protein aggregates comprised of α-synuclein (α-syn). A major barrier in treatment discovery for PD is the lack of identifiable therapeutic pathways capable of reducing aggregates in human neuronal model systems. Mutations in key components of...

Alternative Titles

Full title

α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_jstor_primary_26467761

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_26467761

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1520335113

How to access this item